A study conducted by Dr. Bonn-Miller from the Medical School of the University of Pennsylvania found out that two-thirds of CBD products online show incorrect data on cannabinoid content on their descriptions. Dr. Bonn-Miller's team purchased and tested 84 different online retail products labeled as "contains CBD." The products analyzed came from 31 different online vendors.
A study by Dr. Bonn-Milller of the Medical School of the University of Pennsylvania showed that up to two-thirds of products sold by online retailers show incorrect data on cannabinoid content in their descriptions.
Both in the US and in Europe are fragmented, mainly due to inconsistent legislation. Also, dozens of varying regulations within states and countries.
While most CBD products are not illegal, manufacturers often operate in a grey area. One of the practical consequences of this situation are the different qualities of CBD products.
The results of the study by Dr. Bonn-Miller’s team show, on the one hand, an obvious inaccuracy in the labeling of many CBD products. The Pennsylvania team purchased 84 different online retail products labeled “Contains CBD” from 31 different online vendors.
They test each product a total of three times, with the final results then averaged to the average value. And these were worrying – to put it mildly.
However, 26 percent showed the exact opposite. Only slightly more than 30 percent owned the approximate share of CBD stated on their labels. (Here a margin of 10 percent permits on the part of US pharmacology.)
Interestingly, there were significant differences in the accuracy of the information on the respective labels regarding the product category. Meanwhile, fluids for vaporizers on their labels only achieved a truth content of 12.5 percent.
Especially in relation to vaporizer fluids, they hold the worst average of the content compared to the information on the label. Up to ten times the actual value could exceed or undercut the information.
According to Bonn-Miller’s results, fluctuations in the amount of CBD, a substance with a very good safety profile, are not dangerous, yet they lead the customer in the wrong direction. Finally, an overestimation of the actual content may prevent the purchaser from reaping the tangible benefits of the appropriate dose of CBD.
The conclusion of US research is universal in nature and concerns markets on both sides of the Atlantic. Closer monitoring of CBD products and prudent regulation on this issue appear essential.
The researchers point out that such a deviation. The actual and reported values to show that online merchants are exclusively for shopping. (These shops are usually a little more difficult to control so as not to have to call them obscure.) However, this is no excuse to grant orders online a different status.
Regardless of the efforts of regulatory bodies, the best guarantee for a verified quality in the composition of products is to focus on certified and professional distributors.
Each batch of CannabiGold, for example, is inspected by a multi-inspection that guarantees that the quantity stated on the packaging matches that of the product. And each vial is filled with the optimal composition of natural phytocannabinoids.
—
(Featured Image by Sabrina Rohwer)
First published in Hanf Journal a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
A survey found that women comprise 61% of home cannabis growers, marking a diversion from…
Denmark plans to make its pilot medical cannabis program permanent following its success in treating…
Polish lawmakers have submitted a non-binding petition to Prime Minister Donald Tusk, urging cannabis decriminalization…
The UK medical cannabis market has rapidly grown since legalization in 2018, with private actors…
A new study involving over 23,000 participants in New Zealand found that 60% of people…
The French Ministers of the Interior and Justice announced a comprehensive plan to tackle organized…